Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-03-08
1986-05-27
Robinson, Allen J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514229, 514234, 514237, 514239, A61K 3150, A61K 31495, A61K 31535
Patent
active
045915911
ABSTRACT:
This invention provides for the use of certain pyridazinones as positive inotropic agents.
REFERENCES:
patent: 3845050 (1974-10-01), Lebkuecher et al.
patent: 4258185 (1981-03-01), Nakao et al.
patent: 4304777 (1981-12-01), Lesher et al.
patent: 4353905 (1982-10-01), Sircar et al.
patent: 4361563 (1982-11-01), Austel et al.
patent: 4397854 (1983-08-01), Sircar
patent: 4404203 (1983-09-01), Sircar
Curran et al., J. Med. Chem., 17(3), 273 (1974).
McEvoy et al., J. Med. Chem., 17(3), 281 (1974).
Derwent 27593K/12 Abstracting German OLS No. 3,135,617.
Derwent 18918K/08 Abstracting Japanese Pat. No. J58008016.
Ashbrook Charles W.
Eli Lilly and Company
Robinson Allen J.
Whale Arthur R.
LandOfFree
Pyridazinone derivatives as inotropic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyridazinone derivatives as inotropic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridazinone derivatives as inotropic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1571226